Pooled analysis of cardiac safety in patients with cancer treated with pertuzumab (English)
- New search for: Lenihan, D.
- New search for: Suter, T.
- New search for: Brammer, M.
- New search for: Neate, C.
- New search for: Ross, G.
- New search for: Baselga, J.
- New search for: Lenihan, D.
- New search for: Suter, T.
- New search for: Brammer, M.
- New search for: Neate, C.
- New search for: Ross, G.
- New search for: Baselga, J.
In:
ANNALS OF ONCOLOGY
;
23
, 3
;
791-800
;
2012
-
ISSN:
- Article (Journal) / Print
-
Title:Pooled analysis of cardiac safety in patients with cancer treated with pertuzumab
-
Contributors:Lenihan, D. ( author ) / Suter, T. ( author ) / Brammer, M. ( author ) / Neate, C. ( author ) / Ross, G. ( author ) / Baselga, J. ( author )
-
Published in:ANNALS OF ONCOLOGY ; 23, 3 ; 791-800
-
Publisher:
- New search for: OXFORD UNIVERSITY PRESS
-
Publication date:2012-01-01
-
Size:10 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.992
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.992 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 23, Issue 3
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 545
-
Pulmonary nodules in patients with melanoma-assume nothingMurphy, F. / Gleeson, F. V. / Middleton, M. R. et al. | 2012
- 547
-
Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future?Ribeiro, J. T. / Macedo, L. T. / Curigliano, G. / Fumagalli, L. / Locatelli, M. / Dalton, M. / Quintela, A. / Carvalheira, J. B. / Manunta, S. / Mazzarella, L. et al. | 2012
- 556
-
Trabectedin plus pegylated liposomal doxorubicin in the treatment of patients with partially platinum-sensitive ovarian cancer: current evidence and future perspectivesSehouli, J. / Alfaro, V. / Gonzalez-Martin, A. et al. | 2012
- 562
-
Update on desmoid tumorsEscobar, C. / Munker, R. / Thomas, J. O. / Li, B. D. / Burton, G. V. et al. | 2012
- 570
-
New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert paneldaggerVan Laethem, J. L. / Verslype, C. / Iovanna, J. L. / Michl, P. / Conroy, T. / Louvet, C. / Hammel, P. / Mitry, E. / Ducreux, M. / Maraculla, T. et al. | 2012
- 577
-
Histology and outcomes of newly detected lung lesions in melanoma patientsSmyth, E. C. / Hsu, M. / Panageas, K. S. / Chapman, P. B. et al. | 2012
- 582
-
Locoregional recurrence risk after lipofilling in breast cancer patientsPetit, J. Y. / Botteri, E. / Lohsiriwat, V. / Rietjens, M. / De Lorenzi, F. / Garusi, C. / Rossetto, F. / Martella, S. / Manconi, A. / Bertolini, F. et al. | 2012
- 589
-
Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancerBuzdar, A. U. / Xu, B. / Digumarti, R. / Goedhals, L. / Hu, X. / Semiglazov, V. / Cheporov, S. / Gotovkin, E. / Hoersch, S. / Rittweger, K. et al. | 2012
- 597
-
Zoledronic acid blocks the interaction between mesenchymal stem cells and breast cancer cells: implications for adjuvant therapy of breast cancerGallo, M. / De Luca, A. / Lamura, L. / Normanno, N. et al. | 2012
- 604
-
Death causes in breast cancer patientsRiihimaki, M. / Thomsen, H. / Brandt, A. / Sundquist, J. / Hemminki, K. et al. | 2012
- 610
-
Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapyCampone, M. / Bondarenko, I. / Brincat, S. / Hotko, Y. / Munster, P. N. / Chmielowska, E. / Fumoleau, P. / Ward, R. / Bardy-Bouxin, N. / Leip, E. et al. | 2012
- 618
-
High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patientsPierga, J. Y. / Hajage, D. / Bachelot, T. / Delaloge, S. / Brain, E. / Campone, M. / Dieras, V. / Rolland, E. / Mignot, L. / Mathiot, C. et al. | 2012
- 625
-
Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancerAlbanell, J. / Gonzalez, A. / Ruiz-Borrego, M. / Alba, E. / Garcia-Saenz, J. A. / Corominas, J. M. / Burgues, O. / Furio, V. / Rojo, A. / Palacios, J. et al. | 2012
- 632
-
Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840Lichtman, S. M. / Hurria, A. / Cirrincione, C. T. / Seidman, A. D. / Winer, E. / Hudis, C. / Cohen, H. J. / Muss, H. B. et al. | 2012
- 638
-
Sam68 expression and cytoplasmic localization is correlated with lymph node metastasis as well as prognosis in patients with early-stage cervical cancerLi, Z. / Yu, C. P. / Zhong, Y. / Liu, T. J. / Huang, Q. D. / Zhao, X. H. / Huang, H. / Tu, H. / Jiang, S. / Zhang, Y. et al. | 2012
- 647
-
Intraoperative hyperthermic versus postoperative normothermic intraperitoneal chemotherapy for colonic peritoneal carcinomatosis: a case-control studyCashin, P. H. / Graf, W. / Nygren, P. / Mahteme, H. et al. | 2012
- 652
-
Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendixLieu, C. H. / Lambert, L. A. / Wolff, R. A. / Eng, C. / Zhang, N. / Wen, S. / Rafeeq, S. / Taggart, M. / Fournier, K. / Royal, R. et al. | 2012
- 659
-
Genetic polymorphism of IGF-I predicts recurrence in patients with gastric cancer who have undergone curative gastrectomyShitara, K. / Ito, S. / Misawa, K. / Ito, Y. / Ito, H. / Hosono, S. / Watanabe, M. / Tajima, K. / Tanaka, H. / Muro, K. et al. | 2012
- 664
-
Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancerPera, M. / Gallego, R. / Montagut, C. / Martin-Richard, M. / Iglesias, M. / Conill, C. / Reig, A. / Balague, C. / Petriz, L. / Momblan, D. et al. | 2012
- 670
-
Correlation of cytidine deaminase polymorphisms and activity with clinical outcome in gemcitabine-/platinum-treated advanced non-small-cell lung cancer patientsTibaldi, C. / Giovannetti, E. / Tiseo, M. / Leon, L. G. / DIncecco, A. / Loosekoot, N. / Bartolotti, M. / Honeywell, R. / Cappuzzo, F. / Ardizzoni, A. et al. | 2012
- 678
-
Phase II trial of PTK787/ZK 222584 (vatalanib) administered orally once-daily or in two divided daily doses as second-line monotherapy in relapsed or progressing patients with stage IIIB/IV non-small-cell lung cancer (NSCLC)Gauler, T. C. / Besse, B. / Mauguen, A. / Meric, J. B. / Gounant, V. / Fischer, B. / Overbeck, T. R. / Krissel, H. / Laurent, D. / Tiainen, M. et al. | 2012
- 688
-
Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: a phase 1/2 clinical trialDaggerZurita, A. J. / George, D. J. / Shore, N. D. / Liu, G. / Wilding, G. / Hutson, T. E. / Kozloff, M. / Mathew, P. / Harmon, C. S. / Wang, S. L. et al. | 2012
- 695
-
Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trialCognetti, F. / Ruggeri, E. M. / Felici, A. / Gallucci, M. / Muto, G. / Pollera, C. F. / Massidda, B. / Rubagotti, A. / Giannarelli, D. / Boccardo, F. et al. | 2012
- 701
-
Costs of early adjuvant radiation therapy after radical prostatectomy: a decision analysisShowalter, T. N. / Foley, K. A. / Jutkowitz, E. / Lallas, C. D. / Trabulsi, E. J. / Gomella, L. G. / Dicker, A. P. / Pizzi, L. T. et al. | 2012
- 707
-
Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapyHuang, C. N. / Huang, S. P. / Pao, J. B. / Chang, T. Y. / Lan, Y. H. / Lu, T. L. / Lee, H. Z. / Juang, S. H. / Wu, P. P. / Pu, Y. S. et al. | 2012
- 714
-
Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?Sabatier, R. / Eymard, J. C. / Walz, J. / Deville, J. L. / Narbonne, H. / Boher, J. M. / Salem, N. / Marcy, M. / Brunelle, S. / Viens, P. et al. | 2012
- 722
-
The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients' renal functionDimopoulos, M. A. / Kastritis, E. / Michalis, E. / Tsatalas, C. / Michael, M. / Pouli, A. / Kartasis, Z. / Delimpasi, S. / Gika, D. / Zomas, A. et al. | 2012
- 729
-
Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletionMian, M. / Scandurra, M. / Chigrinova, E. / Shen, Y. / Inghirami, G. / Greiner, T. C. / Chan, W. C. / Vose, J. M. / Testoni, M. / Chiappella, A. et al. | 2012
- 736
-
Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkins lymphomaAzambuja, D. / Natkunam, Y. / Biasoli, I. / Lossos, I. S. / Anderson, M. W. / Morais, J. C. / Spector, N. et al. | 2012
- 743
-
Prospective evaluation of corrected QT intervals and arrhythmias after exposure to epirubicin, cyclophosphamide, and 5-fluorouracil in women with breast cancerKitagawa, K. / Kawada, K. / Morita, S. / Inada, M. / Mitsuma, A. / Sawaki, M. / Iino, S. / Inden, Y. / Murohara, T. / Imai, T. et al. | 2012
- 748
-
Chemotherapy dose reductions in obese patients with colorectal cancerChambers, P. / Daniels, S. H. / Thompson, L. C. / Stephens, R. J. et al. | 2012
- 754
-
Association of body mass index in early adulthood and middle age with future site-specific cancer mortality: the Harvard Alumni Health StudyGray, L. / Lee, I. M. / Sesso, H. D. / Batty, G. D. et al. | 2012
- 760
-
Power and limits of modern cancer diagnostics: cancer of unknown primaryHemminki, K. / Liu, H. / Heminki, A. / Sundquist, J. et al. | 2012
- 765
-
Dietary patterns and the risk of esophageal cancerBravi, F. / Edefonti, V. / Randi, G. / Garavello, W. / La Vecchia, C. / Ferraroni, M. / Talamini, R. / Franceschi, S. / Decarli, A. et al. | 2012
- 771
-
Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcomaGronchi, A. / Bui, B. N. / Bonvalot, S. / Pilotti, S. / Ferrari, S. / Hohenberger, P. / Hohl, R. J. / Demetri, G. D. / Le Cesne, A. / Lardelli, P. et al. | 2012
- 777
-
High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trialBui-Nguyen, B. / Ray-Coquard, I. / Chevreau, C. / Penel, N. / Bay, J. O. / Coindre, J. M. / Cupissol, D. / Italiano, A. / Bonichon, F. / Lotz, J. P. et al. | 2012
- 785
-
Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimenVerschraegen, C. F. / Arias-Pulido, H. / Lee, S. J. / Movva, S. / Cerilli, L. A. / Eberhardt, S. / Schmit, B. / Quinn, R. / Muller, C. Y. / Rabinowitz, I. et al. | 2012
- 791
-
Pooled analysis of cardiac safety in patients with cancer treated with pertuzumabLenihan, D. / Suter, T. / Brammer, M. / Neate, C. / Ross, G. / Baselga, J. et al. | 2012
- 801
-
Bringing geriatrics into oncology or also oncology into geriatrics?Monfardini, S. / Giordano, G. / Sandri, R. / Gnocchi, P. L. / Galetti, G. et al. | 2012
- 801
-
Aprepitant quetiapine: a clinically significant drug interaction in a patient treated for head and neck cancerVerwimp-Hoeks, M. P. / van Herpen, C. M. / Burger, D. M. et al. | 2012
- 802
-
About locoregional recurrence risk after lipofilling in breast cancer patientsSemprini, G. / Cattin, F. / Lazzaro, L. / Cedolini, C. / Parodi, P. C. et al. | 2012
- 803
-
Reply to about locoregional recurrence risk after lipofilling in breast cancer patientsPetit, J. Y. / Lohsiriwat, V. / Rietjens, M. et al. | 2012
- 804
-
Clinical activity of sorafenib in patients with advanced gastrointestinal stromal tumor bearing PDGFRA exon 18 mutation: a case seriesRoubaud, G. / Kind, M. / Coindre, J. M. / Maki, R. G. / Bui, B. / Italiano, A. et al. | 2012
- 805
-
Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)Zinzani, P. L. / Derenzini, E. / Pellegrini, C. / Rigacci, L. / Fabbri, A. / Gandolfi, L. / Argnani, L. / Casadei, B. / Pulsoni, A. / Gobbi, M. et al. | 2012
- 807
-
Objective response to sorafenib in advanced clear-cell sarcomaMir, O. / Boudou-Rouquette, P. / Larousserie, F. / Babinet, A. / Dumaine, V. / Anract, P. / Goldwasser, F. et al. | 2012
- 807
-
Reply to Rituxan is not associated with Stevens-Johnson syndromeParise, L. / Kahle, J. / Schlaak, M. / Mauch, C. / Kurschat, P. et al. | 2012
- 810
-
errata| 2012